Principle Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+5,171
New +$239K 0.01% 378
2026
Q2
– Sell
-3,392
Closed -$213K – 400
2026
Q1
$213K Sell
3,392
-33
-1% -$2.64K 0.01% 359
2025
Q4
$327K Buy
3,425
+21
+0.6% +$2.06K 0.02% 299
2025
Q3
$332K Hold
3,404
– – 0.02% 290
2025
Q2
$366K Buy
3,404
+5
+0.1% +$506 0.02% 276
2025
Q1
$343K Hold
3,399
– – 0.02% 268
2024
Q4
$304K Buy
3,399
+25
+0.7% +$2.2K 0.02% 282
2024
Q3
$283K Hold
3,374
– – 0.02% 294
2024
Q2
$260K Hold
3,374
– – 0.02% 291
2024
Q1
$231K Buy
+3,374
New +$217K 0.02% 316
2020
Q3
– Sell
-2,590
Closed -$91K – 184
2020
Q2
$91K Buy
+2,590
New +$93.3K 0.03% 222

Other funds holding BSX

Principle Wealth Partners's BSX Position: Q3 2026 in Review

Principle Wealth Partners opened a new position in Boston Scientific (BSX) in Q3 2026: 5,171 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #378 among its holdings. This is a return to the name: Principle Wealth Partners previously reported a position in BSX as recently as Q1 2026.

Principle Wealth Partners first reported a position in BSX in Q2 2020 and has held it in 11 quarters since. The position peaked at $366K in Q2 2025. 826 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Principle Wealth Partners held 5,171 shares of Boston Scientific worth $226K as of Q3 2026.
  • Boston Scientific was a new Principle Wealth Partners position in Q3 2026.
  • Boston Scientific made up 0.01% of Principle Wealth Partners's portfolio in Q3 2026, its #378 holding.
  • Principle Wealth Partners first reported a position in Boston Scientific in Q2 2020 and has held it in 11 quarters since.
  • Principle Wealth Partners's Boston Scientific position peaked at $366K in Q2 2025.
  • 826 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Principle Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.